Literature DB >> 25894544

HMGA1-pseudogene expression is induced in human pituitary tumors.

Francesco Esposito1, Marco De Martino, Daniela D'Angelo, Paula Mussnich, Gerald Raverot, Marie-Lise Jaffrain-Rea, Filippo Fraggetta, Jacqueline Trouillas, Alfredo Fusco.   

Abstract

Numerous studies have established that High Mobility Group A (HMGA) proteins play a pivotal role on the onset of human pituitary tumors. They are overexpressed in pituitary tumors, and, consistently, transgenic mice overexpressing either the Hmga1 or the Hmga2 gene develop pituitary tumors. In contrast with HMGA2, HMGA1 overexpression is not related to any rearrangement or amplification of the HMGA1 locus in these tumors. We have recently identified 2 HMGA1 pseudogenes, HMGA1P6 and HMGA1P7, acting as competitive endogenous RNA decoys for HMGA1 and other cancer related genes. Here, we show that HMGA1 pseudogene expression significantly correlates with HMGA1 mRNA levels in growth hormone and nonfunctioning pituitary adenomas likely inhibiting the repression of HMGA1 through microRNAs action. According to our functional studies, these HMGA1 pseudogenes enhance the proliferation and migration of the mouse pituitary tumor cell line, at least in part, through their upregulation. Our results point out that the overexpression of HMGA1P6 and HMGA1P7 could contribute to increase HMGA1 levels in human pituitary tumors, and then to pituitary tumorigenesis.

Entities:  

Keywords:  HMGA1; HMGA1P6; HMGA1P7; ceRNA; miRNA

Mesh:

Substances:

Year:  2015        PMID: 25894544      PMCID: PMC4615119          DOI: 10.1080/15384101.2015.1021520

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  16 in total

1.  HMGA1 and HMGA2 protein expression correlates with advanced tumour grade and lymph node metastasis in pancreatic adenocarcinoma.

Authors:  Salvatore Piscuoglio; Inti Zlobec; Pierlorenzo Pallante; Romina Sepe; Francesco Esposito; Arthur Zimmermann; Ioannis Diamantis; Luigi Terracciano; Alfredo Fusco; Eva Karamitopoulou
Journal:  Histopathology       Date:  2012-02       Impact factor: 5.087

Review 2.  Role of the high mobility group A proteins in the regulation of pituitary cell cycle.

Authors:  Monica Fedele; Alfredo Fusco
Journal:  J Mol Endocrinol       Date:  2010-03-10       Impact factor: 5.098

Review 3.  Critical role of the HMGA2 gene in pituitary adenomas.

Authors:  Monica Fedele; Giovanna Maria Pierantoni; Rosa Visone; Alfredo Fusco
Journal:  Cell Cycle       Date:  2006-09-15       Impact factor: 4.534

4.  PIT1 upregulation by HMGA proteins has a role in pituitary tumorigenesis.

Authors:  Dario Palmieri; Teresa Valentino; Ivana De Martino; Francesco Esposito; Paolo Cappabianca; Anne Wierinckx; Michela Vitiello; Gaetano Lombardi; Annamaria Colao; Jacqueline Trouillas; Giovanna Maria Pierantoni; Alfredo Fusco; Monica Fedele
Journal:  Endocr Relat Cancer       Date:  2012-04-10       Impact factor: 5.678

5.  HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity.

Authors:  Monica Fedele; Rosa Visone; Ivana De Martino; Giancarlo Troncone; Dario Palmieri; Sabrina Battista; Andrea Ciarmiello; Pierlorenzo Pallante; Claudio Arra; Rosa Marina Melillo; Kristian Helin; Carlo Maria Croce; Alfredo Fusco
Journal:  Cancer Cell       Date:  2006-06       Impact factor: 31.743

Review 6.  Roles of HMGA proteins in cancer.

Authors:  Alfredo Fusco; Monica Fedele
Journal:  Nat Rev Cancer       Date:  2007-12       Impact factor: 60.716

7.  HAND1 gene expression is negatively regulated by the High Mobility Group A1 proteins and is drastically reduced in human thyroid carcinomas.

Authors:  J Martinez Hoyos; A Ferraro; S Sacchetti; S Keller; I De Martino; E Borbone; P Pallante; M Fedele; D Montanaro; F Esposito; P Cserjesi; L Chiariotti; G Troncone; A Fusco
Journal:  Oncogene       Date:  2008-12-08       Impact factor: 9.867

8.  Altered microRNA expression profile in human pituitary GH adenomas: down-regulation of miRNA targeting HMGA1, HMGA2, and E2F1.

Authors:  Daniela D'Angelo; Dario Palmieri; Paula Mussnich; Magali Roche; Anne Wierinckx; Gerald Raverot; Monica Fedele; Carlo Maria Croce; Jacqueline Trouillas; Alfredo Fusco
Journal:  J Clin Endocrinol Metab       Date:  2012-05-07       Impact factor: 5.958

9.  Enhancer of zeste homolog 2 overexpression has a role in the development of anaplastic thyroid carcinomas.

Authors:  Eleonora Borbone; Giancarlo Troncone; Angelo Ferraro; Zuzana Jasencakova; Lovorka Stojic; Francesco Esposito; Nadine Hornig; Alfredo Fusco; Valerio Orlando
Journal:  J Clin Endocrinol Metab       Date:  2011-02-02       Impact factor: 5.958

10.  HMGA1 pseudogenes as candidate proto-oncogenic competitive endogenous RNAs.

Authors:  Francesco Esposito; Marco De Martino; Maria Grazia Petti; Floriana Forzati; Mara Tornincasa; Antonella Federico; Claudio Arra; Giovanna Maria Pierantoni; Alfredo Fusco
Journal:  Oncotarget       Date:  2014-09-30
View more
  27 in total

1.  miR-16 regulates proliferation and apoptosis of pituitary adenoma cells by inhibiting HMGA2.

Authors:  Yingying Niu; Hongbo Zhou; Yancui Liu; Yunfeng Wang; Jinding Xie; Chong Feng; Ning An
Journal:  Oncol Lett       Date:  2018-12-28       Impact factor: 2.967

2.  High Mobility Group A proteins in esophageal carcinomas.

Authors:  Antonio Palumbo Júnior; Nathalia Meireles Da Costa; Francesco Esposito; Alfredo Fusco; Luis Felipe Ribeiro Pinto
Journal:  Cell Cycle       Date:  2016-08-02       Impact factor: 4.534

Review 3.  High Mobility Group A1 (HMGA1): Structure, Biological Function, and Therapeutic Potential.

Authors:  Lu Wang; Ji Zhang; Min Xia; Chang Liu; Xuyu Zu; Jing Zhong
Journal:  Int J Biol Sci       Date:  2022-07-04       Impact factor: 10.750

4.  Characterization of HMGA1P6 transgenic mouse embryonic fibroblasts.

Authors:  Marco De Martino; Giuseppe Palma; Claudio Arra; Paolo Chieffi; Alfredo Fusco; Francesco Esposito
Journal:  Cell Cycle       Date:  2020-08-13       Impact factor: 4.534

5.  RPSAP52 lncRNA is overexpressed in pituitary tumors and promotes cell proliferation by acting as miRNA sponge for HMGA proteins.

Authors:  Daniela D'Angelo; Paula Mussnich; Romina Sepe; Maddalena Raia; Luigi Del Vecchio; Paolo Cappabianca; Simona Pellecchia; Sara Petrosino; Serena Saggio; Domenico Solari; Filippo Fraggetta; Alfredo Fusco
Journal:  J Mol Med (Berl)       Date:  2019-05-10       Impact factor: 4.599

6.  The HMGA1-pseudogene7 shows oncogenic activity in vivo.

Authors:  Marco De Martino; Francesco Esposito; Alfredo Fusco
Journal:  Cell Cycle       Date:  2020-10-10       Impact factor: 4.534

Review 7.  Critical role of the high mobility group A proteins in hematological malignancies.

Authors:  Marco De Martino; Francesco Esposito; Alfredo Fusco
Journal:  Hematol Oncol       Date:  2021-10-12       Impact factor: 4.850

Review 8.  Epigenetic Mechanisms Leading to Overexpression of HMGA Proteins in Human Pituitary Adenomas.

Authors:  Daniela D'Angelo; Francesco Esposito; Alfredo Fusco
Journal:  Front Med (Lausanne)       Date:  2015-06-08

9.  FTH1P3, a Novel H-Ferritin Pseudogene Transcriptionally Active, Is Ubiquitously Expressed and Regulated during Cell Differentiation.

Authors:  Maddalena Di Sanzo; Ilenia Aversa; Gianluca Santamaria; Monica Gagliardi; Mariafranca Panebianco; Flavia Biamonte; Fabiana Zolea; Maria Concetta Faniello; Giovanni Cuda; Francesco Costanzo
Journal:  PLoS One       Date:  2016-03-16       Impact factor: 3.240

Review 10.  Pseudogenes in Human Cancer.

Authors:  Laura Poliseno; Andrea Marranci; Pier Paolo Pandolfi
Journal:  Front Med (Lausanne)       Date:  2015-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.